These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17199722

  • 1. Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus.
    Tavintharan S, Lim SC, Chan YH, Sum CF.
    Diabetes Obes Metab; 2007 Jan; 9(1):81-6. PubMed ID: 17199722
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
    Donnelly LA, Palmer CN, Whitley AL, Lang CC, Doney AS, Morris AD, Donnan PT.
    Pharmacogenet Genomics; 2008 Apr; 18(4):279-87. PubMed ID: 18334912
    [Abstract] [Full Text] [Related]

  • 3. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS.
    Chin Med J (Engl); 2005 Apr 05; 118(7):555-60. PubMed ID: 15820086
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.
    Curr Med Res Opin; 2007 Sep 05; 23(9):2125-33. PubMed ID: 17655813
    [Abstract] [Full Text] [Related]

  • 5. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.
    Clin Biochem; 2007 Oct 05; 40(15):1150-6. PubMed ID: 17689519
    [Abstract] [Full Text] [Related]

  • 6. Identification of genetic variants associated with response to statin therapy.
    Mega JL, Morrow DA, Brown A, Cannon CP, Sabatine MS.
    Arterioscler Thromb Vasc Biol; 2009 Sep 05; 29(9):1310-5. PubMed ID: 19667110
    [Abstract] [Full Text] [Related]

  • 7. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.
    Ilveskoski E, Lehtimäki T, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Laippala P, Karhunen PJ, Knuuti J.
    Scand J Clin Lab Invest; 2007 Sep 05; 67(7):723-34. PubMed ID: 17852827
    [Abstract] [Full Text] [Related]

  • 8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 05; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 9. Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients.
    Ying S, Sun YM, Liu XM, An CY, Gao YY.
    Biochem Biophys Res Commun; 2007 Nov 16; 363(2):395-8. PubMed ID: 17870053
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C.
    Miller M, Dobs A, Yuan Z, Battisti WP, Borisute H, Palmisano J.
    Curr Med Res Opin; 2004 Jul 16; 20(7):1087-94. PubMed ID: 15265253
    [Abstract] [Full Text] [Related]

  • 11. [Distribution of apoE polymorphism in Chinese Yunnan Dehong Dai ethnic group].
    Tang H, Yan X, Hua Y, Wei M, Zhang L, Gao J, Dong H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr 16; 22(2):224-6. PubMed ID: 15793794
    [Abstract] [Full Text] [Related]

  • 12. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C, Richard F, Fiévet N, Dartigues JF, Ritchie K, Tzourio C, Amouyel P, Alpérovitch A.
    Neurology; 2005 May 10; 64(9):1531-8. PubMed ID: 15883313
    [Abstract] [Full Text] [Related]

  • 13. The influence of apolipoprotein B and E gene polymorphisms on the response to simvastatin therapy in patients with hyperlipidemia.
    Ye P, Shang Y, Ding X.
    Chin Med Sci J; 2003 Mar 10; 18(1):9-13. PubMed ID: 12901521
    [Abstract] [Full Text] [Related]

  • 14. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
    Vossen CY, Hoffmann MM, Hahmann H, Wüsten B, Rothenbacher D, Brenner H.
    Clin Pharmacol Ther; 2008 Aug 10; 84(2):222-7. PubMed ID: 18388879
    [Abstract] [Full Text] [Related]

  • 15. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
    Donnelly LA, Doney AS, Dannfald J, Whitley AL, Lang CC, Morris AD, Donnan PT, Palmer CN.
    Pharmacogenet Genomics; 2008 Dec 10; 18(12):1021-6. PubMed ID: 18815589
    [Abstract] [Full Text] [Related]

  • 16. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
    Bhavani AB, Sastry KB, Reddy NK, Padma T.
    Indian Heart J; 2005 Dec 10; 57(2):151-7. PubMed ID: 16013355
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 10; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
    Wong TY, Shankar A, Klein R, Bray MS, Couper DJ, Klein BE, Sharrett AR, Folsom AR.
    Ophthalmology; 2006 Feb 10; 113(2):255-9. PubMed ID: 16406547
    [Abstract] [Full Text] [Related]

  • 19. Treatment of hyperlipidemia in primary practise in Germany: sub-group analyses from the 4E-registry with particular emphasis on men and women with diabetes mellitus.
    Assmann G, Schulte H, Cullen P, Neiss A, Bestehorn K.
    Exp Clin Endocrinol Diabetes; 2007 Feb 10; 115(2):85-91. PubMed ID: 17318766
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians.
    Rontu R, Ojala P, Hervonen A, Goebeler S, Karhunen PJ, Nikkilä M, Kunnas T, Jylhä M, Eklund C, Hurme M, Lehtimäki T.
    Clin Endocrinol (Oxf); 2006 Mar 10; 64(3):265-70. PubMed ID: 16487435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.